BERGER FRANKLIN M sold 44.3% of their position (359.61K shares) of ATEA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.02M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/12/2024ACC: 0000950170-24-135930
Director
Since Oct 2020
-359.61K
Net shares
Net seller
$1.02M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
359.61K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−359.61K
Price / share
$2.85
Trade value
$1.02M
% of position
44.3%
12/10/2024
811.50K→451.90K
Total
Net shares
−359.61K
Net value
-$1.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2024 | S · Sale | −359.61K | $2.85 | $1.02M | 44.3% | 811.50K | 451.90K |
| Total | −359.61K | -$1.02M | ||||||
Derivative Transactions0
No derivative transactions reported